GLEN ALLEN, Va.--(BUSINESS WIRE)--Osteologix, Inc. (OTCBB: OLGX) today announced that the Company will make two presentations focused on the Company’s lead osteoporosis drug candidate, NB S101, at the Biotechnology Industry Organization (BIO) International Convention on June 17 and June 18, 2008 at the San Diego Convention Center.
